tak 779 has been researched along with st-246 in 1 studies
| Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (st-246) | Trials (st-246) | Recent Studies (post-2010) (st-246) |
|---|---|---|---|---|---|
| 118 | 1 | 35 | 88 | 6 | 55 |
| Protein | Taxonomy | tak 779 (IC50) | st-246 (IC50) |
|---|---|---|---|
| Envelope phospholipase F13 | Vaccinia virus WR | 0.0027 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, QY; Dong, MX; Jiang, S; Lu, H; Peng, XQ; Yun, LH; Zhang, J | 1 |
1 other study(ies) available for tak 779 and st-246
| Article | Year |
|---|---|
Tricyclononene carboxamide derivatives as novel anti-HIV-1 agents.
Topics: Anti-HIV Agents; Cell Line; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; HIV-1; Inhibitory Concentration 50; Models, Molecular; Molecular Conformation | 2010 |